CRP and cancer: Recently, inflammatory markers including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), serum C-reactive protein (CRP), modified Glasgow prognostic score (mGPS), absolute eosinophil count, and serum lactate dehydrogenase (LDH) have been reported to be useful predictors of progression of cancer including SDC42,43.